Chemical compositions and antifungal activities of Satureja macrosiphon against Candida and Aspergillus species

Document Type : Original Articles


1 Department of Medical Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

2 Department of Horticultural Sciences, Faculty of Agriculture, Shiraz University, Shiraz, Iran

3 Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

4 Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

5 Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran


Background and Purpose: Despite the various applications of Satureja species, there are limited data in this domain. Regarding this, the present study was conducted to investigate the essential oil (EO) biological activity of S. macrosiphon species in Iran.
Materials and Methods: The EO of S. macrosiphon flowers was obtained by hydrodistillation. Chemical compositions of the EO were analyzed using gas chromatography-mass spectrometry. In addition, minimum inhibitory concentrations (MIC) were measured by means of the broth microdilution method. The estimation of antibiofilm and cytotoxic activities was also accomplished using the tetrazolium salt and MTT assays, respectively.
Results: A total of 26 components were identified in the EO with linalool as the main constituent (28.46%). A MIC range value of 0.25-8 μL/mL was obtained against all of the tested fungi. The EO inhibited the biofilm development of the Candida tested strains at a concentration of 4-8 μL/mL. Cytotoxicity (IC50) of EO against the HeLa cell was greater than the MIC concentration (6.49 μL/mL).
Conclusion: Based on the findings, it was concluded that the EO of S. macrosiphon has the potential for further use as an antifungal agent.


1. Vazquez JA, Miceli MH, Alangaden G. Invasive fungal infections in transplant recipients. Ther Adv Infect Dis. 2013; 1(3):85-105.
2. Person AK, Kontoyiannis DP, Alexander BD. Fungal infections in transplant and oncology patients. Hematol Oncol Clin. 2011; 25(1):193-213.
3. Mousset S, Buchheidt D, Heinz W, Ruhnke M, Cornely OA, Egerer G, et al. Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2014; 93(1):13-32.
4. Badiee P, Hashemizadeh Z. Opportunistic invasive fungal infections: diagnosis & clinical management. Indian J Med Res. 2014; 139(2):195-204.
5. Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi. 2017; 3(4):E57.
6. Caston-Osorio J, Rivero A, Torre-Cisneros J. Epidemiology of invasive fungal infection. Int J Antimicrob Agents. 2008; 32(Suppl 2):S103-9.
7. Lehrnbecher T, Frank C, Engels K, Kriener S, Groll AH, Schwabe D. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect. 2010; 61(3):259-65.
8. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis. 1995; 20(6):1526-30.
9. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007; 45(4):321-46.
10. Jantunen E, Anttila VJ, Ruutu T. Aspergillus infections in
allogeneic stem cell transplant recipients: have we made any progress? Bone Marrow Transplant. 2002; 30(12):925-9.
11. Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine. 2000; 79(4):250-60.
12. Sanglard D. Emerging threats in antifungal-resistant fungal pathogens. Front Med. 2016; 3:11.
13. Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench M-T, et al. Candida spp. with acquired echinocandin resistance, France, 2004-2010. Emerg Infect Dis. 2012; 18(1):86-90.
14. Jensen RH, Johansen HK, Arendrup MC. Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis. Antimicrob Agents Chemother. 2013; 57(1):614-7.
15. Riat A, Plojoux J, Gindro K, Schrenzel J, Sanglard D. Azole resistance of environmental and clinical Aspergillus fumigatus isolates from Switzerland. Antimicrob Agents Chemother. 2018; 62(4):e02088-17.
16. Breda CA, Gasperini AM, Garcia VL, Monteiro KM, Bataglion GA, Eberlin MN, et al. Phytochemical analysis and antifungal activity of extracts from leaves and fruit residues of Brazilian Savanna plants aiming its use as safe fungicides. Nat Prod Bioprospect. 2016; 6(4):195-204.
17. El-Khateeb AY, Elsherbiny E, Tadros L, Ali S, Hamed H. Phytochemical analysis and antifungal activity of fruit leaves extracts on the mycelial growth of fungal plant pathogens. J Plant Pathol Microbiol. 2013; 4(9):1-6.
18. Patel P, Patel N, Patel D, Desai SH, Meshram D. Phytochemical analysis and antifungal activity of Moringa oleifera. Int J Pharm Pharm Sci. 2014; 6(5):144-7.
19. Azaz AD, Kürkcüoglu M, Satil F, Can Baser KH, Tümen G. In vitro antimicrobial activity and chemical composition of some Satureja essential oils. Flavour Fragr J. 2005; 20(6):587-91.
20. Zeidan-Chulia F, Keskin M, Kononen E, Uitto VJ, Soderling E, Moreira JC, et al. Antibacterial and antigelatinolytic effects of Satureja hortensis L. essential oil on epithelial cells exposed to Fusobacterium nucleatum. J Med Food. 2015; 18(4):503-6.
21. Farzaneh M, Kiani H, Sharifi R, Reisi M, Hadian J. Chemical composition and antifungal effects of three species of Satureja (S. hortensis, S. spicigera, and S. khuzistanica) essential oils on the main pathogens of strawberry fruit. Postharvest Biol Technol. 2015; 109:145-51.
22. Bezic N, Dunkic V, Elma V. Antiphytoviral activity of essential oils of some Lamiaceae species and there most important compounds on CMV and TMV. Microbial pathogens and strategies for combating them: science, technology and education. Spain: Formatex Research Center; 2013.
23. Bagheri S, Ahmadvand H, Khosrowbeygi A, Ghazanfari F, Jafari N, Nazem H, et al. Antioxidant properties and inhibitory effects of Satureja khozestanica essential oil on LDL oxidation induced–CuSO(4) in vitro. Asian Pac J Trop Biomed. 2013; 3(1):22-7.
24. Adams RP. Identification of essential oil components by gas chromatography/mass spectrometry. 5th ed. Mexico: Texensis Publishing; 2017.
25. Alastruey-Izquierdo A, Melhem MS, Bonfietti LX, Rodriguez-Tudela JL. Susceptibility test for fungi: clinical and laboratorial correlations in medical mycology. Rev Inst Med Trop Sao Paulo. 2015; 57(Suppl 19):57-64.
26. Sabaeifard P, Abdi-Ali A, Soudi MR, Dinarvand R. Optimization of tetrazolium salt assay for Pseudomonas aeruginosa biofilm using microtiter plate method. J Microbiol Methods. 2014; 105:134-40.
27. Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, et al. Cell viability assays. Maryland: National Center for Advancing Translational Sciences; 2016.
28. Saharkhiz MJ, Zomorodian K, Taban A, Pakshir K, Heshmati K, Rahimi MJ. Chemical composition and antimicrobial activities of three Satureja Species against food-borne pathogens. J Essentiol Oil Bear Plants. 2016; 19(8):1984-92.
29. Amiri H. The in vitro antioxidative properties of the essential oils and methanol extracts of Satureja macrosiphonia Bornm. Nat Prod Res. 2011; 25(3):232-43.
30. Trombetta D, Castelli F, Sarpietro MG, Venuti V, Cristani M, Daniele C, et al. Mechanisms of antibacterial action of three monoterpenes. Antimicrob Agents Chemother. 2005; 49(6): 2474-8.
31. Kundakovic T, Stanojkovic T, Kolundzija B, Markovic S, Sukilovic B, Milenkovic M, et al. Cytotoxicity and antimicrobial activity of the essential oil from Satureja montana subsp. pisidica (Lamiceae). Nat Prod Commun. 2014; 9(4):569-72.
32. Bukvicki D, Stojkovic D, Sokovic M, Vannini L, Montanari C, Pejin B, et al. Satureja horvatii essential oil: in vitro antimicrobial and antiradical properties and in situ control of Listeria monocytogenes in pork meat. Meat Sci. 2014; 96(3):1355-60.
33. Gorran A, Salehnia B, Farzaneh HR, Farzaneh M, Shivazad M. Effect of essential oils and extracts of Satureja macrosiphon and Satureja khozistanica on mycelial growth and aflatoxin B1 production in Aspergillus flavus. J Vet Res. 2015; 70(2):139-45.
34. Slavkovska V, Jancic R, Bojovic S, Milosavljevic S, Djokovic D. Variability of essential oils of Satureja montana L. and Satureja kitaibelii wierzb. ex Heuff. from the central part of the balkan peninsula. Phytochemistry. 2001; 57(1):71-6.
35. Kremer D, Kosir IJ, Koncic MZ, Cerenak A, Potocnik T, Srecec
S, et al. Antimicrobial and antioxidant properties of Satureja montana L. and S. subspicata Vis.(Lamiaceae). Curr Drug Targets. 2015; 16(14):1623-33.
36. Park M, Gwak K, Yang I, Kim K, Jeung E, Chang J, et al. Effect of citral, eugenol, nerolidol and α-terpineol on the ultrastructural changes of Trichophyton mentagrophytes. Fitoterapia. 2009; 80(5):290-6.
37. Cha JD, Jung EK, Kil BS, Lee KY. Chemical composition and antibacterial activity of essential oil from Artemisia feddei. J Microbiol Biotechnol. 2007; 17(12):2061-5.
38. Alviano W, Mendonca‐Filho R, Alviano D, Bizzo H, Souto‐Padron T, Rodrigues M, et al. Antimicrobial activity of Croton cajucara Benth linalool‐rich essential oil on artificial biofilms and planktonic microorganisms. Oral Microbiol Immunol. 2005; 20(2):101-5.
39. Ramage G, Rajendran R, Sherry L, Williams C. Fungal biofilm resistance. Int J Microbiol. 2012; 2012:528521.
40. Manoharan RK, Lee JH, Kim YG, Kim SI, Lee J. Inhibitory effects of the essential oils α-longipinene and linalool on biofilm formation and hyphal growth of Candida albicans. Biofouling. 2017; 33(2):143-55.